000			02337 a2200721 4500
005			20250513152922.0
264		0	_c19981109
008			199811s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aDe Botton, S
245	0	0	_aIncidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. _h[electronic resource]
260			_bBlood _cOct 1998
300			_a2712-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAcute Kidney Injury _xchemically induced
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibiotics, Antineoplastic _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCardiovascular Diseases _xchemically induced
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDexamethasone _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aLeukemia, Promyelocytic, Acute _xdrug therapy
650	0	4	_aLeukocyte Count _xdrug effects
650	0	4	_aLife Tables
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPericardial Effusion _xchemically induced
650	0	4	_aPleural Effusion _xchemically induced
650	0	4	_aProportional Hazards Models
650	0	4	_aRemission Induction
650	0	4	_aRespiration Disorders _xchemically induced
650	0	4	_aSurvival Rate
650	0	4	_aSyndrome
650	0	4	_aTreatment Outcome
650	0	4	_aTretinoin _xadverse effects
700	1		_aDombret, H
700	1		_aSanz, M
700	1		_aMiguel, J S
700	1		_aCaillot, D
700	1		_aZittoun, R
700	1		_aGardembas, M
700	1		_aStamatoulas, A
700	1		_aCondé, E
700	1		_aGuerci, A
700	1		_aGardin, C
700	1		_aGeiser, K
700	1		_aMakhoul, D C
700	1		_aReman, O
700	1		_ade la Serna, J
700	1		_aLefrere, F
700	1		_aChomienne, C
700	1		_aChastang, C
700	1		_aDegos, L
700	1		_aFenaux, P
773	0		_tBlood _gvol. 92 _gno. 8 _gp. 2712-8
999			_c9728383 _d9728383